PHIO

#5181
Phio Pharmaceuticals Corp. - Common Stock
0.0 1 USD
-99.03%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
0.01
0.01
Year Range
0.01
1.35
Daily Change
-99.03%
Monthly Change
-99.08%
6 month change
-99.07%
Year Change
-99.07%
Previous Close
1.1 4
Open
0.0 1
Low
0.0 1
High
0.0 1
Volume
5
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
Income statement Balance sheet Cash flow
Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM

Phio Pharmaceuticals Corp. - Common Stock

Phio Pharmaceuticals Corporation is a US clinical stage biotechnology company developing its INTASYL siRNA in immuno-oncology. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018.

News